Mike Kama

3.1k total citations
66 papers, 1.3k citations indexed

About

Mike Kama is a scholar working on Infectious Diseases, Epidemiology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Mike Kama has authored 66 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Infectious Diseases, 19 papers in Epidemiology and 18 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Mike Kama's work include Dermatological diseases and infestations (14 papers), Viral Infections and Vectors (11 papers) and Leptospirosis research and findings (10 papers). Mike Kama is often cited by papers focused on Dermatological diseases and infestations (14 papers), Viral Infections and Vectors (11 papers) and Leptospirosis research and findings (10 papers). Mike Kama collaborates with scholars based in Fiji, Australia and United Kingdom. Mike Kama's co-authors include Colleen L. Lau, Eric J. Nilles, John Kaldor, Lucia Romani, Andrew C. Steer, Margot Whitfeld, Conall Watson, Handan Wand, John H. Lowry and Lisi Tikoduadua and has published in prestigious journals such as New England Journal of Medicine, Nature Communications and SHILAP Revista de lepidopterología.

In The Last Decade

Mike Kama

65 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mike Kama Fiji 20 748 318 283 278 172 66 1.3k
Paweł Stefanoff Poland 23 616 0.8× 358 1.1× 373 1.3× 630 2.3× 73 0.4× 79 1.8k
Harold Noël France 17 765 1.0× 822 2.6× 290 1.0× 175 0.6× 74 0.4× 45 1.7k
Yin Wenwu China 24 825 1.1× 737 2.3× 192 0.7× 395 1.4× 123 0.7× 62 1.6k
Conall Watson United Kingdom 20 518 0.7× 318 1.0× 136 0.5× 378 1.4× 46 0.3× 49 1.1k
Lucille Blumberg South Africa 26 879 1.2× 663 2.1× 137 0.5× 718 2.6× 49 0.3× 114 2.2k
Sunny Mak Canada 23 933 1.2× 250 0.8× 324 1.1× 854 3.1× 40 0.2× 46 1.6k
Kristy Bradley United States 14 515 0.7× 392 1.2× 428 1.5× 164 0.6× 33 0.2× 30 1.1k
Katrin Leitmeyer Sweden 18 1.0k 1.3× 724 2.3× 121 0.4× 294 1.1× 64 0.4× 44 1.6k
Andrew L. Corwin United States 30 1.2k 1.7× 767 2.4× 358 1.3× 567 2.0× 125 0.7× 74 2.3k
Victoria Ng Canada 21 387 0.5× 328 1.0× 50 0.2× 178 0.6× 47 0.3× 55 1.0k

Countries citing papers authored by Mike Kama

Since Specialization
Citations

This map shows the geographic impact of Mike Kama's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mike Kama with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mike Kama more than expected).

Fields of papers citing papers by Mike Kama

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mike Kama. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mike Kama. The network helps show where Mike Kama may publish in the future.

Co-authorship network of co-authors of Mike Kama

This figure shows the co-authorship network connecting the top 25 collaborators of Mike Kama. A scholar is included among the top collaborators of Mike Kama based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mike Kama. Mike Kama is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hu, Yi‐Juan, et al.. (2025). Azithromycin alters the microbiome composition, function and resistome in women with Chlamydia trachomatis infections. npj Biofilms and Microbiomes. 11(1). 235–235.
3.
Joseph, Sandeep J., et al.. (2023). Patterns of within-host spread of Chlamydia trachomatis between vagina, endocervix and rectum revealed by comparative genomic analysis. Frontiers in Microbiology. 14. 1154664–1154664. 4 indexed citations
4.
Rafai, Eric, Mike Kama, Meciusela Tuicakau, et al.. (2022). Costs of mass drug administration for scabies in Fiji. PLoS neglected tropical diseases. 16(2). e0010147–e0010147. 4 indexed citations
5.
Jenney, Adam, Daniel Engelman, Lucia Romani, et al.. (2021). Prospective surveillance for invasive Staphylococcus aureus and group A Streptococcus infections in a setting with high community burden of scabies and impetigo. International Journal of Infectious Diseases. 108. 333–339. 5 indexed citations
6.
Hardy, Myra, Mike Kama, Meciusela Tuicakau, et al.. (2020). The safety of combined triple drug therapy with ivermectin, diethylcarbamazine and albendazole in the neglected tropical diseases co-endemic setting of Fiji: A cluster randomised trial. PLoS neglected tropical diseases. 14(3). e0008106–e0008106. 16 indexed citations
7.
Jenney, Adam, Daniel Engelman, Lucia Romani, et al.. (2020). Hospital admissions for skin and soft tissue infections in a population with endemic scabies: A prospective study in Fiji, 2018–2019. PLoS neglected tropical diseases. 14(12). e0008887–e0008887. 9 indexed citations
10.
Henderson, Alasdair, Maïté Aubry, Mike Kama, et al.. (2020). Zika seroprevalence declines and neutralizing antibodies wane in adults following outbreaks in French Polynesia and Fiji. eLife. 9. 42 indexed citations
11.
Togami, Eri, Narayan Gyawali, Mike Kama, et al.. (2020). First evidence of concurrent enzootic and endemic transmission of Ross River virus in the absence of marsupial reservoirs in Fiji. International Journal of Infectious Diseases. 96. 94–96. 11 indexed citations
12.
Prasad, Namrata, Aaron Jenkins, Mike Kama, et al.. (2018). Epidemiology and risk factors for typhoid fever in Central Division, Fiji, 2014–2017: A case-control study. PLoS neglected tropical diseases. 12(6). e0006571–e0006571. 29 indexed citations
13.
Mayfield, Helen J., John H. Lowry, Conall Watson, et al.. (2018). Use of geographically weighted logistic regression to quantify spatial variation in the environmental and sociodemographic drivers of leptospirosis in Fiji: a modelling study. The Lancet Planetary Health. 2(5). e223–e232. 51 indexed citations
14.
Lau, Colleen L., Helen J. Mayfield, John H. Lowry, et al.. (2017). Unravelling infectious disease eco-epidemiology using Bayesian networks and scenario analysis: A case study of leptospirosis in Fiji. Environmental Modelling & Software. 97. 271–286. 19 indexed citations
15.
Watson, Conall, Stefan Flasche, Adam J. Kucharski, et al.. (2017). Social mixing in Fiji: Who-eats-with-whom contact patterns and the implications of age and ethnic heterogeneity for disease dynamics in the Pacific Islands. PLoS ONE. 12(12). e0186911–e0186911. 5 indexed citations
16.
Watson, Conall, Stephen Baker, Colleen L. Lau, et al.. (2017). A cross-sectional seroepidemiological survey of typhoid fever in Fiji. PLoS neglected tropical diseases. 11(7). e0005786–e0005786. 49 indexed citations
17.
Reid, Simon, et al.. (2017). A process for developing multisectoral strategies for zoonoses: the case of leptospirosis in Fiji. BMC Public Health. 17(1). 671–671. 8 indexed citations
18.
Lau, Colleen L., Conall Watson, John H. Lowry, et al.. (2016). Human Leptospirosis Infection in Fiji: An Eco-epidemiological Approach to Identifying Risk Factors and Environmental Drivers for Transmission. PLoS neglected tropical diseases. 10(1). e0004405–e0004405. 119 indexed citations
19.
Cocks, Naomi, Colin Macleod, Stephanie J Migchelsen, et al.. (2016). Community seroprevalence survey for yaws and trachoma in the Western Division of Fiji. Transactions of the Royal Society of Tropical Medicine and Hygiene. 110(10). 582–587. 15 indexed citations
20.
Romani, Lucia, Andrew C. Steer, Mike Kama, et al.. (2015). Scabies and Impetigo Prevalence and Risk Factors in Fiji: A National Survey. PLoS neglected tropical diseases. 9(3). e0003452–e0003452. 111 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026